Link to a more detailed article at the bottom.
- "Penn researchers first reported on this type of successful T cell treatment last year. Three adults were treated and two had complete remission. Their cases were detailed in the New England Journal of Medicine and Science Translational Medicine in August 2011.
Two years after treatment, the two adults still have no evidence of disease — they also still have the engineered T cells present in their bodies, a major scientific breakthrough, researchers said.
“The problem is that lots of people have figured out how to engineer T cells, lots of people figured out how to grow T cells in a lab, but nobody figured out how to make the cells actually grow in the patient,” Grupp said.
That is, until now.
This weekend, researchers shared new data showing that nine of 12 patients with advanced leukemia in the clinical trial, including Emily and another child after her, responded to treatment.
“When we first treated our first three adults ... the results came back over a period of six weeks, and at that point I knew that my life was forever changed,” said June, the Richard W. Vague professor in immunotherapy in the department of pathology and laboratory medicine and director of translational research in Penn’s Abramson Cancer Center." -
Read more here:
http://www.centredaily.com/2012/12/09/3430...6#storylink=cpy